instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'DONEPEZIL HYDROCHLORIDE'? | Development of donepezil-induced hypokalemia following treatment of cognitive impairment.
Donepezil is a cholinesterase inhibitor used extensively to treat Alzheimer disease. The increased cholinergic activity is associated with adverse effects, therefore gastrointestinal symptoms, including nausea, vomiting, and diarr... | 5 mg (milligrams). | DrugDosage | CC BY-NC | 33045804 | 18,435,143 | 2021-01 |
What was the dosage of drug 'DONEPEZIL'? | Development of donepezil-induced hypokalemia following treatment of cognitive impairment.
Donepezil is a cholinesterase inhibitor used extensively to treat Alzheimer disease. The increased cholinergic activity is associated with adverse effects, therefore gastrointestinal symptoms, including nausea, vomiting, and diarr... | 5 mg (milligrams). | DrugDosage | CC BY-NC | 33045804 | 18,430,605 | 2021-01 |
What was the outcome of reaction 'Hypokalaemia'? | Development of donepezil-induced hypokalemia following treatment of cognitive impairment.
Donepezil is a cholinesterase inhibitor used extensively to treat Alzheimer disease. The increased cholinergic activity is associated with adverse effects, therefore gastrointestinal symptoms, including nausea, vomiting, and diarr... | Recovered | ReactionOutcome | CC BY-NC | 33045804 | 18,430,605 | 2021-01 |
What was the outcome of reaction 'Pneumonia'? | Development of donepezil-induced hypokalemia following treatment of cognitive impairment.
Donepezil is a cholinesterase inhibitor used extensively to treat Alzheimer disease. The increased cholinergic activity is associated with adverse effects, therefore gastrointestinal symptoms, including nausea, vomiting, and diarr... | Recovering | ReactionOutcome | CC BY-NC | 33045804 | 18,742,345 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
There is limited evidence to support pharmacogenetic (PGx) testing in children. We conducted a retrospective review of PGx testing among 452 patients at an academic children's hospital to determine the potential utility of PGx in diseas... | ARIPIPRAZOLE | DrugsGivenReaction | CC BY-NC | 33048453 | 19,917,576 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ascites'. | The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis.
Approximately 20-50% patients with chronic phase chronic myeloid leukemia (CML-CP) treated with tyrosine kinase inhibitors (TKIs) or with myelofibrosis (MF) treated... | DASATINIB | DrugsGivenReaction | CC BY-NC | 33054123 | 20,176,531 | 2021-11-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis.
Approximately 20-50% patients with chronic phase chronic myeloid leukemia (CML-CP) treated with tyrosine kinase inhibitors (TKIs) or with myelofibrosis (MF) treated... | DASATINIB | DrugsGivenReaction | CC BY-NC | 33054123 | 20,176,531 | 2021-11-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatosplenomegaly'. | The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis.
Approximately 20-50% patients with chronic phase chronic myeloid leukemia (CML-CP) treated with tyrosine kinase inhibitors (TKIs) or with myelofibrosis (MF) treated... | DASATINIB | DrugsGivenReaction | CC BY-NC | 33054123 | 20,176,531 | 2021-11-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis.
Approximately 20-50% patients with chronic phase chronic myeloid leukemia (CML-CP) treated with tyrosine kinase inhibitors (TKIs) or with myelofibrosis (MF) treated... | DASATINIB | DrugsGivenReaction | CC BY-NC | 33054123 | 20,176,531 | 2021-11-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urogenital haemorrhage'. | The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis.
Approximately 20-50% patients with chronic phase chronic myeloid leukemia (CML-CP) treated with tyrosine kinase inhibitors (TKIs) or with myelofibrosis (MF) treated... | DASATINIB | DrugsGivenReaction | CC BY-NC | 33054123 | 20,176,531 | 2021-11-01 |
What was the outcome of reaction 'Gastrointestinal haemorrhage'? | The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis.
Approximately 20-50% patients with chronic phase chronic myeloid leukemia (CML-CP) treated with tyrosine kinase inhibitors (TKIs) or with myelofibrosis (MF) treated... | Fatal | ReactionOutcome | CC BY-NC | 33054123 | 20,176,531 | 2021-11-01 |
What was the outcome of reaction 'Urogenital haemorrhage'? | The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis.
Approximately 20-50% patients with chronic phase chronic myeloid leukemia (CML-CP) treated with tyrosine kinase inhibitors (TKIs) or with myelofibrosis (MF) treated... | Fatal | ReactionOutcome | CC BY-NC | 33054123 | 20,176,531 | 2021-11-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Anti-leucine-rich glioma-inactivated 1 (LGI1) antibody is associated with limbic encephalitis. We herein report a patient with anti-LGI1 encephalitis who developed severe orthostatic hypotension (OH) responsive to immun... | AMLODIPINE BESYLATE, CARBAMAZEPINE, DROXIDOPA, FLUDROCORTISONE, METHYLPREDNISOLONE, MIDODRINE, PYRIDOSTIGMINE | DrugsGivenReaction | CC BY-NC-ND | 33055478 | 20,836,871 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Anti-leucine-rich glioma-inactivated 1 (LGI1) antibody is associated with limbic encephalitis. We herein report a patient with anti-LGI1 encephalitis who developed severe orthostatic hypotension (OH) responsive to immun... | AMLODIPINE BESYLATE, CARBAMAZEPINE, DROXIDOPA, FLUDROCORTISONE, METHYLPREDNISOLONE, MIDODRINE, PYRIDOSTIGMINE | DrugsGivenReaction | CC BY-NC-ND | 33055478 | 20,836,871 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Orthostatic hypotension'. | Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Anti-leucine-rich glioma-inactivated 1 (LGI1) antibody is associated with limbic encephalitis. We herein report a patient with anti-LGI1 encephalitis who developed severe orthostatic hypotension (OH) responsive to immun... | AMLODIPINE BESYLATE, CARBAMAZEPINE, DROXIDOPA, FLUDROCORTISONE, METHYLPREDNISOLONE, MIDODRINE, PYRIDOSTIGMINE | DrugsGivenReaction | CC BY-NC-ND | 33055478 | 20,836,871 | 2021-09-15 |
What was the dosage of drug 'CARBAMAZEPINE'? | Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Anti-leucine-rich glioma-inactivated 1 (LGI1) antibody is associated with limbic encephalitis. We herein report a patient with anti-LGI1 encephalitis who developed severe orthostatic hypotension (OH) responsive to immun... | 400 MG | DrugDosageText | CC BY-NC-ND | 33055478 | 20,836,871 | 2021-09-15 |
What was the dosage of drug 'DROXIDOPA'? | Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Anti-leucine-rich glioma-inactivated 1 (LGI1) antibody is associated with limbic encephalitis. We herein report a patient with anti-LGI1 encephalitis who developed severe orthostatic hypotension (OH) responsive to immun... | 900 MG, QD | DrugDosageText | CC BY-NC-ND | 33055478 | 20,836,871 | 2021-09-15 |
What was the dosage of drug 'FLUDROCORTISONE'? | Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Anti-leucine-rich glioma-inactivated 1 (LGI1) antibody is associated with limbic encephalitis. We herein report a patient with anti-LGI1 encephalitis who developed severe orthostatic hypotension (OH) responsive to immun... | 0.2 MG, QD | DrugDosageText | CC BY-NC-ND | 33055478 | 20,836,871 | 2021-09-15 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Anti-leucine-rich glioma-inactivated 1 (LGI1) antibody is associated with limbic encephalitis. We herein report a patient with anti-LGI1 encephalitis who developed severe orthostatic hypotension (OH) responsive to immun... | 1000 MG, QD | DrugDosageText | CC BY-NC-ND | 33055478 | 20,836,871 | 2021-09-15 |
What was the dosage of drug 'MIDODRINE'? | Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Anti-leucine-rich glioma-inactivated 1 (LGI1) antibody is associated with limbic encephalitis. We herein report a patient with anti-LGI1 encephalitis who developed severe orthostatic hypotension (OH) responsive to immun... | 6 MG, QD | DrugDosageText | CC BY-NC-ND | 33055478 | 20,836,871 | 2021-09-15 |
What was the dosage of drug 'PYRIDOSTIGMINE'? | Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Anti-leucine-rich glioma-inactivated 1 (LGI1) antibody is associated with limbic encephalitis. We herein report a patient with anti-LGI1 encephalitis who developed severe orthostatic hypotension (OH) responsive to immun... | 120 MG, QD | DrugDosageText | CC BY-NC-ND | 33055478 | 20,836,871 | 2021-09-15 |
What was the outcome of reaction 'Orthostatic hypotension'? | Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Anti-leucine-rich glioma-inactivated 1 (LGI1) antibody is associated with limbic encephalitis. We herein report a patient with anti-LGI1 encephalitis who developed severe orthostatic hypotension (OH) responsive to immun... | Recovering | ReactionOutcome | CC BY-NC-ND | 33055478 | 20,836,871 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood corticotrophin decreased'. | Oral Contraceptive Disturbed the Recovery of the Adrenal Function after Adrenalectomy in Cushing Syndrome.
Estrogen is known to increase exogenous corticosteroid levels. In this case, a 27-year-old Japanese woman was referred to our hospital for examination of an adrenal tumor and was diagnosed with Cushing syndrome. R... | AMLODIPINE BESYLATE, DROSPIRENONE\ETHINYL ESTRADIOL, HYDROCORTISONE, METYRAPONE | DrugsGivenReaction | CC BY-NC-ND | 33055479 | 19,217,578 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cortisol increased'. | Oral Contraceptive Disturbed the Recovery of the Adrenal Function after Adrenalectomy in Cushing Syndrome.
Estrogen is known to increase exogenous corticosteroid levels. In this case, a 27-year-old Japanese woman was referred to our hospital for examination of an adrenal tumor and was diagnosed with Cushing syndrome. R... | AMLODIPINE BESYLATE, DROSPIRENONE\ETHINYL ESTRADIOL, HYDROCORTISONE, METYRAPONE | DrugsGivenReaction | CC BY-NC-ND | 33055479 | 19,217,578 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Oral Contraceptive Disturbed the Recovery of the Adrenal Function after Adrenalectomy in Cushing Syndrome.
Estrogen is known to increase exogenous corticosteroid levels. In this case, a 27-year-old Japanese woman was referred to our hospital for examination of an adrenal tumor and was diagnosed with Cushing syndrome. R... | AMLODIPINE BESYLATE, DROSPIRENONE\ETHINYL ESTRADIOL, HYDROCORTISONE, METYRAPONE | DrugsGivenReaction | CC BY-NC-ND | 33055479 | 19,217,578 | 2021-03-15 |
What was the administration route of drug 'DROSPIRENONE\ETHINYL ESTRADIOL'? | Oral Contraceptive Disturbed the Recovery of the Adrenal Function after Adrenalectomy in Cushing Syndrome.
Estrogen is known to increase exogenous corticosteroid levels. In this case, a 27-year-old Japanese woman was referred to our hospital for examination of an adrenal tumor and was diagnosed with Cushing syndrome. R... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33055479 | 19,217,578 | 2021-03-15 |
What was the administration route of drug 'HYDROCORTISONE'? | Oral Contraceptive Disturbed the Recovery of the Adrenal Function after Adrenalectomy in Cushing Syndrome.
Estrogen is known to increase exogenous corticosteroid levels. In this case, a 27-year-old Japanese woman was referred to our hospital for examination of an adrenal tumor and was diagnosed with Cushing syndrome. R... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33055479 | 19,217,578 | 2021-03-15 |
What was the dosage of drug 'DROSPIRENONE\ETHINYL ESTRADIOL'? | Oral Contraceptive Disturbed the Recovery of the Adrenal Function after Adrenalectomy in Cushing Syndrome.
Estrogen is known to increase exogenous corticosteroid levels. In this case, a 27-year-old Japanese woman was referred to our hospital for examination of an adrenal tumor and was diagnosed with Cushing syndrome. R... | 3/0.02MG DAILY | DrugDosageText | CC BY-NC-ND | 33055479 | 19,217,578 | 2021-03-15 |
What was the dosage of drug 'HYDROCORTISONE'? | Oral Contraceptive Disturbed the Recovery of the Adrenal Function after Adrenalectomy in Cushing Syndrome.
Estrogen is known to increase exogenous corticosteroid levels. In this case, a 27-year-old Japanese woman was referred to our hospital for examination of an adrenal tumor and was diagnosed with Cushing syndrome. R... | 15?20MG DAILY | DrugDosageText | CC BY-NC-ND | 33055479 | 19,217,578 | 2021-03-15 |
What was the outcome of reaction 'Blood corticotrophin decreased'? | Oral Contraceptive Disturbed the Recovery of the Adrenal Function after Adrenalectomy in Cushing Syndrome.
Estrogen is known to increase exogenous corticosteroid levels. In this case, a 27-year-old Japanese woman was referred to our hospital for examination of an adrenal tumor and was diagnosed with Cushing syndrome. R... | Recovered | ReactionOutcome | CC BY-NC-ND | 33055479 | 19,217,578 | 2021-03-15 |
What was the outcome of reaction 'Cortisol increased'? | Oral Contraceptive Disturbed the Recovery of the Adrenal Function after Adrenalectomy in Cushing Syndrome.
Estrogen is known to increase exogenous corticosteroid levels. In this case, a 27-year-old Japanese woman was referred to our hospital for examination of an adrenal tumor and was diagnosed with Cushing syndrome. R... | Recovered | ReactionOutcome | CC BY-NC-ND | 33055479 | 19,217,578 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delirium'. | Impact of Geriatric Pharmacy Specialist Interventions to Reduce Potentially Inappropriate Medication Among Hospitalized Elderly Patients at Medical Wards: A Prospective Quasi-Experimental Study.
BACKGROUND
Elderly patients are at greater risk of receiving potentially inappropriate medications (PIMs) and developing adve... | CYPROHEPTADINE | DrugsGivenReaction | CC BY-NC | 33063296 | 19,406,939 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stress fracture'. | Clinical and Radiological Characterization of Patients with Immobilizing and Progressive Stress Fractures in Methotrexate Osteopathy.
Methotrexate (MTX) is one of the most commonly prescribed drugs for autoimmune rheumatic diseases. As there is no consensus on its negative effects on bone, the purpose of this investiga... | METHOTREXATE | DrugsGivenReaction | CC BY | 33064170 | 18,451,574 | 2021-02 |
What was the dosage of drug 'METHOTREXATE'? | Clinical and Radiological Characterization of Patients with Immobilizing and Progressive Stress Fractures in Methotrexate Osteopathy.
Methotrexate (MTX) is one of the most commonly prescribed drugs for autoimmune rheumatic diseases. As there is no consensus on its negative effects on bone, the purpose of this investiga... | 18.6 +/- 4.9 MG (15-25 MG) WEEKLY | DrugDosageText | CC BY | 33064170 | 18,451,574 | 2021-02 |
What was the outcome of reaction 'Stress fracture'? | Clinical and Radiological Characterization of Patients with Immobilizing and Progressive Stress Fractures in Methotrexate Osteopathy.
Methotrexate (MTX) is one of the most commonly prescribed drugs for autoimmune rheumatic diseases. As there is no consensus on its negative effects on bone, the purpose of this investiga... | Recovering | ReactionOutcome | CC BY | 33064170 | 18,451,574 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Torsade de pointes'. | Torsade de pointes induced by intravenous amiodarone therapy accompanied by marked augmentation of the transmural dispersion of repolarization in a patient with tachycardia-induced-cardiomyopathy.
We report a 77-year-old human on renal dialysis for end-stage renal disease with heart failure and atrial fibrillation (AF)... | AMIODARONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33070441 | 18,469,623 | 2021-05 |
What was the administration route of drug 'AMIODARONE HYDROCHLORIDE'? | Torsade de pointes induced by intravenous amiodarone therapy accompanied by marked augmentation of the transmural dispersion of repolarization in a patient with tachycardia-induced-cardiomyopathy.
We report a 77-year-old human on renal dialysis for end-stage renal disease with heart failure and atrial fibrillation (AF)... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33070441 | 18,469,623 | 2021-05 |
What was the outcome of reaction 'Torsade de pointes'? | Torsade de pointes induced by intravenous amiodarone therapy accompanied by marked augmentation of the transmural dispersion of repolarization in a patient with tachycardia-induced-cardiomyopathy.
We report a 77-year-old human on renal dialysis for end-stage renal disease with heart failure and atrial fibrillation (AF)... | Recovered | ReactionOutcome | CC BY | 33070441 | 18,469,623 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatitis'. | Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb.
Serious concerns are expressed on the safe use of red yeast rice (RYR) supplements. The aim of the present study was to analyse cases received by Lareb on RYR-relate... | ACETAMINOPHEN, AMITRIPTYLINE, CARBASPIRIN CALCIUM, CHOLECALCIFEROL, DIETARY SUPPLEMENT, METOCLOPRAMIDE, METOPROLOL, MORPHINE, NADROPARIN, OXAZEPAM, PANTOPRAZOLE | DrugsGivenReaction | CC BY-NC | 33085778 | 19,715,798 | 2021-04 |
What was the outcome of reaction 'Cholecystitis'? | Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb.
Serious concerns are expressed on the safe use of red yeast rice (RYR) supplements. The aim of the present study was to analyse cases received by Lareb on RYR-relate... | Recovering | ReactionOutcome | CC BY-NC | 33085778 | 19,715,717 | 2021-04 |
What was the outcome of reaction 'Pancreatitis acute'? | Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb.
Serious concerns are expressed on the safe use of red yeast rice (RYR) supplements. The aim of the present study was to analyse cases received by Lareb on RYR-relate... | Recovering | ReactionOutcome | CC BY-NC | 33085778 | 19,715,717 | 2021-04 |
What was the outcome of reaction 'Pancreatitis'? | Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb.
Serious concerns are expressed on the safe use of red yeast rice (RYR) supplements. The aim of the present study was to analyse cases received by Lareb on RYR-relate... | Recovered | ReactionOutcome | CC BY-NC | 33085778 | 19,715,798 | 2021-04 |
What was the outcome of reaction 'Potentiating drug interaction'? | Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb.
Serious concerns are expressed on the safe use of red yeast rice (RYR) supplements. The aim of the present study was to analyse cases received by Lareb on RYR-relate... | Recovering | ReactionOutcome | CC BY-NC | 33085778 | 19,715,717 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aphasia'. | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 33087671 | 18,566,076 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Carotid artery occlusion'. | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 33087671 | 18,566,076 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral artery occlusion'. | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 33087671 | 18,566,076 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral infarction'. | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 33087671 | 18,566,076 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhagic cerebral infarction'. | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 33087671 | 18,476,765 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhagic infarction'. | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 33087671 | 18,566,076 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hemiparesis'. | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 33087671 | 18,566,076 | 2021-03-15 |
What is the weight of the patient? | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | 67.9 kg. | Weight | CC BY-NC-ND | 33087671 | 18,476,765 | 2021-03-15 |
What was the administration route of drug 'CISPLATIN'? | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33087671 | 18,476,765 | 2021-03-15 |
What was the dosage of drug 'RADIATION THERAPY'? | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | 60 GY | DrugDosageText | CC BY-NC-ND | 33087671 | 19,243,011 | 2021-03-15 |
What was the outcome of reaction 'Aortic thrombosis'? | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | Recovered | ReactionOutcome | CC BY-NC-ND | 33087671 | 18,566,076 | 2021-03-15 |
What was the outcome of reaction 'Carotid artery occlusion'? | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33087671 | 18,566,076 | 2021-03-15 |
What was the outcome of reaction 'Cerebral artery occlusion'? | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33087671 | 18,566,076 | 2021-03-15 |
What was the outcome of reaction 'Cerebral infarction'? | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33087671 | 18,566,076 | 2021-03-15 |
What was the outcome of reaction 'Embolic stroke'? | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33087671 | 19,243,011 | 2021-03-15 |
What was the outcome of reaction 'Haemorrhagic cerebral infarction'? | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | Recovered | ReactionOutcome | CC BY-NC-ND | 33087671 | 18,476,765 | 2021-03-15 |
What was the outcome of reaction 'Haemorrhagic infarction'? | Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magneti... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33087671 | 18,566,076 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | CHOLECALCIFEROL, DARBEPOETIN ALFA, ENALAPRIL, ENOXAPARIN SODIUM, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, LEVOTHYROXINE, PENICILLIN V, RANITIDINE, SODIUM CHLORIDE, WARFARIN | DrugsGivenReaction | CC BY | 33089377 | 19,416,137 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anticoagulation drug level above therapeutic'. | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | ALBUMIN HUMAN, INDOMETHACIN, OMEPRAZOLE SODIUM, WARFARIN | DrugsGivenReaction | CC BY | 33089377 | 18,591,197 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Catheter site haemorrhage'. | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | ALBUMIN HUMAN, INDOMETHACIN, OMEPRAZOLE SODIUM, WARFARIN | DrugsGivenReaction | CC BY | 33089377 | 18,591,197 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | CHOLECALCIFEROL, DARBEPOETIN ALFA, ENALAPRIL, ENOXAPARIN SODIUM, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, LEVOTHYROXINE, PENICILLIN V, RANITIDINE, SODIUM CHLORIDE, WARFARIN | DrugsGivenReaction | CC BY | 33089377 | 19,416,137 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematemesis'. | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | ALBUMIN HUMAN, INDOMETHACIN, OMEPRAZOLE SODIUM, WARFARIN | DrugsGivenReaction | CC BY | 33089377 | 18,591,197 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematochezia'. | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | ALBUMIN HUMAN, INDOMETHACIN, OMEPRAZOLE SODIUM, WARFARIN | DrugsGivenReaction | CC BY | 33089377 | 18,591,197 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoglobin decreased'. | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | ALBUMIN HUMAN, INDOMETHACIN, OMEPRAZOLE SODIUM, WARFARIN | DrugsGivenReaction | CC BY | 33089377 | 18,591,197 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'International normalised ratio increased'. | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | ALBUMIN HUMAN, INDOMETHACIN, OMEPRAZOLE SODIUM, WARFARIN | DrugsGivenReaction | CC BY | 33089377 | 18,591,197 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Post procedural haemorrhage'. | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | ALBUMIN HUMAN, INDOMETHACIN, OMEPRAZOLE SODIUM, WARFARIN | DrugsGivenReaction | CC BY | 33089377 | 18,591,197 | 2021-05 |
What was the administration route of drug 'ALBUMIN HUMAN'? | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33089377 | 18,591,197 | 2021-05 |
What was the administration route of drug 'DARBEPOETIN ALFA'? | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33089377 | 19,416,137 | 2021-05 |
What was the administration route of drug 'ENOXAPARIN SODIUM'? | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | Subcutaneous | DrugAdministrationRoute | CC BY | 33089377 | 19,416,137 | 2021-05 |
What was the administration route of drug 'FUROSEMIDE'? | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33089377 | 19,416,137 | 2021-05 |
What was the administration route of drug 'OMEPRAZOLE SODIUM'? | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33089377 | 18,591,197 | 2021-05 |
What was the dosage of drug 'ESOMEPRAZOLE MAGNESIUM'? | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | STARTED AFTER FIRST BLEEDING EVENT | DrugDosageText | CC BY | 33089377 | 19,416,137 | 2021-05 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | 1MMOL/ML | DrugDosageText | CC BY | 33089377 | 19,416,137 | 2021-05 |
What was the outcome of reaction 'Anaemia'? | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Congenital nephrotic syndrome (CNS) is an ultra-rare disease associated with a pro-thrombotic state and venous thromboembolisms (VTE). There is very limited evidence evaluating thromboprophylaxis in patients with CNS. This s... | Recovered | ReactionOutcome | CC BY | 33089377 | 19,416,137 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperlactacidaemia'. | Prevalence and risk factors of lactic acidosis in children with acute moderate and severe asthma, a prospective observational study.
Lactic acidosis is a common complication of status asthmaticus in adults. However, data is sparse in children. The aim of this study was to describe the prevalence and risk factors for la... | ALBUTEROL SULFATE | DrugsGivenReaction | CC BY | 33089387 | 18,487,237 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lactic acidosis'. | Prevalence and risk factors of lactic acidosis in children with acute moderate and severe asthma, a prospective observational study.
Lactic acidosis is a common complication of status asthmaticus in adults. However, data is sparse in children. The aim of this study was to describe the prevalence and risk factors for la... | ALBUTEROL | DrugsGivenReaction | CC BY | 33089387 | 18,517,670 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic acidosis'. | Prevalence and risk factors of lactic acidosis in children with acute moderate and severe asthma, a prospective observational study.
Lactic acidosis is a common complication of status asthmaticus in adults. However, data is sparse in children. The aim of this study was to describe the prevalence and risk factors for la... | ALBUTEROL SULFATE | DrugsGivenReaction | CC BY | 33089387 | 18,487,237 | 2021-04 |
What was the administration route of drug 'OXYCODONE'? | Considering additive effects of polypharmacy : Analysis of adverse events in geriatric patients in long-term care facilities.
BACKGROUND
Potential additive effects of polypharmacy are rarely considered in adverse events of geriatric patients living in long-term care facilities. Our aim, therefore, was to identify adver... | Oral | DrugAdministrationRoute | CC BY | 33090261 | 20,066,723 | 2021-08 |
What was the dosage of drug 'DULOXETINE'? | Considering additive effects of polypharmacy : Analysis of adverse events in geriatric patients in long-term care facilities.
BACKGROUND
Potential additive effects of polypharmacy are rarely considered in adverse events of geriatric patients living in long-term care facilities. Our aim, therefore, was to identify adver... | UNK (HIGH DOSES OF DULOXETINE ) | DrugDosageText | CC BY | 33090261 | 20,066,723 | 2021-08 |
What was the dosage of drug 'OXYCODONE'? | Considering additive effects of polypharmacy : Analysis of adverse events in geriatric patients in long-term care facilities.
BACKGROUND
Potential additive effects of polypharmacy are rarely considered in adverse events of geriatric patients living in long-term care facilities. Our aim, therefore, was to identify adver... | UNK (HIGH DOSES OF OXYCODONE) | DrugDosageText | CC BY | 33090261 | 20,066,723 | 2021-08 |
What was the outcome of reaction 'Confusional state'? | Considering additive effects of polypharmacy : Analysis of adverse events in geriatric patients in long-term care facilities.
BACKGROUND
Potential additive effects of polypharmacy are rarely considered in adverse events of geriatric patients living in long-term care facilities. Our aim, therefore, was to identify adver... | Recovering | ReactionOutcome | CC BY | 33090261 | 20,027,693 | 2021-08 |
What was the outcome of reaction 'Dizziness'? | Considering additive effects of polypharmacy : Analysis of adverse events in geriatric patients in long-term care facilities.
BACKGROUND
Potential additive effects of polypharmacy are rarely considered in adverse events of geriatric patients living in long-term care facilities. Our aim, therefore, was to identify adver... | Recovering | ReactionOutcome | CC BY | 33090261 | 20,027,693 | 2021-08 |
What was the outcome of reaction 'Hallucination'? | Considering additive effects of polypharmacy : Analysis of adverse events in geriatric patients in long-term care facilities.
BACKGROUND
Potential additive effects of polypharmacy are rarely considered in adverse events of geriatric patients living in long-term care facilities. Our aim, therefore, was to identify adver... | Recovering | ReactionOutcome | CC BY | 33090261 | 20,027,693 | 2021-08 |
What was the outcome of reaction 'Somnolence'? | Considering additive effects of polypharmacy : Analysis of adverse events in geriatric patients in long-term care facilities.
BACKGROUND
Potential additive effects of polypharmacy are rarely considered in adverse events of geriatric patients living in long-term care facilities. Our aim, therefore, was to identify adver... | Recovering | ReactionOutcome | CC BY | 33090261 | 20,027,693 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatotoxicity'. | First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies.
Nonalcoholic fatty liver disease (NAFLD) is increasingly being linked to o... | ACETAMINOPHEN, AMPICILLIN SODIUM\SULBACTAM SODIUM, DEXAMETHASONE, ONDANSETRON | DrugsGivenReaction | CC BY | 33090351 | 18,518,353 | 2021-02 |
What was the administration route of drug 'AMPICILLIN SODIUM\SULBACTAM SODIUM'? | First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies.
Nonalcoholic fatty liver disease (NAFLD) is increasingly being linked to o... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33090351 | 18,518,353 | 2021-02 |
What was the administration route of drug 'DEXAMETHASONE'? | First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies.
Nonalcoholic fatty liver disease (NAFLD) is increasingly being linked to o... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33090351 | 18,525,642 | 2021-02 |
What was the administration route of drug 'ONDANSETRON'? | First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies.
Nonalcoholic fatty liver disease (NAFLD) is increasingly being linked to o... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33090351 | 18,518,353 | 2021-02 |
What was the dosage of drug 'ACETAMINOPHEN\HYDROCODONE'? | First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies.
Nonalcoholic fatty liver disease (NAFLD) is increasingly being linked to o... | 1 GRAM | DrugDosageText | CC BY | 33090351 | 18,525,642 | 2021-02 |
What was the dosage of drug 'ONDANSETRON'? | First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies.
Nonalcoholic fatty liver disease (NAFLD) is increasingly being linked to o... | 8 mg (milligrams). | DrugDosage | CC BY | 33090351 | 18,518,353 | 2021-02 |
What was the outcome of reaction 'Hepatotoxicity'? | First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies.
Nonalcoholic fatty liver disease (NAFLD) is increasingly being linked to o... | Recovering | ReactionOutcome | CC BY | 33090351 | 18,518,353 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytokine release syndrome'. | Filgrastim associations with CAR T-cell therapy.
Little is known about the benefits and risks of myeloid growth factor administration after chimeric antigen receptor (CAR) T-cell therapy for diffuse large B-cell lymphoma (DLBCL). We present a retrospective analysis among 22 relapsed/refractory DLBCL patients who receiv... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 33091961 | 18,449,659 | 2021-03-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diffuse large B-cell lymphoma'. | Filgrastim associations with CAR T-cell therapy.
Little is known about the benefits and risks of myeloid growth factor administration after chimeric antigen receptor (CAR) T-cell therapy for diffuse large B-cell lymphoma (DLBCL). We present a retrospective analysis among 22 relapsed/refractory DLBCL patients who receiv... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 33091961 | 18,449,659 | 2021-03-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Filgrastim associations with CAR T-cell therapy.
Little is known about the benefits and risks of myeloid growth factor administration after chimeric antigen receptor (CAR) T-cell therapy for diffuse large B-cell lymphoma (DLBCL). We present a retrospective analysis among 22 relapsed/refractory DLBCL patients who receiv... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 33091961 | 18,449,659 | 2021-03-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune effector cell-associated neurotoxicity syndrome'. | Filgrastim associations with CAR T-cell therapy.
Little is known about the benefits and risks of myeloid growth factor administration after chimeric antigen receptor (CAR) T-cell therapy for diffuse large B-cell lymphoma (DLBCL). We present a retrospective analysis among 22 relapsed/refractory DLBCL patients who receiv... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 33091961 | 18,449,659 | 2021-03-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Filgrastim associations with CAR T-cell therapy.
Little is known about the benefits and risks of myeloid growth factor administration after chimeric antigen receptor (CAR) T-cell therapy for diffuse large B-cell lymphoma (DLBCL). We present a retrospective analysis among 22 relapsed/refractory DLBCL patients who receiv... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 33091961 | 18,449,659 | 2021-03-01 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Filgrastim associations with CAR T-cell therapy.
Little is known about the benefits and risks of myeloid growth factor administration after chimeric antigen receptor (CAR) T-cell therapy for diffuse large B-cell lymphoma (DLBCL). We present a retrospective analysis among 22 relapsed/refractory DLBCL patients who receiv... | 500 MILLIGRAM/SQ. METER, QD | DrugDosageText | CC BY-NC | 33091961 | 18,449,659 | 2021-03-01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.